CBLB502 is a polypeptide drug derived from a portion of Salmonella flagellin that binds to and potently activates TLR5.
CBLB502是一种多肽药物,它来源于沙门氏菌鞭毛蛋白的一部分,结合并有效地激活tlr5。
When these animals received the teeming gut world of the TLR5-deficient mice, they too began eating more and developed the same metabolic-syndrome symptoms that their donors had.
接受了转移来的肠道微生物的普通小鼠也开始表现出进食更多的食物并像突变的小鼠一样,也逐步表现出代谢综合征症状。
应用推荐